drugset / Trial / NCT03990636

Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial

NCT03990636

Phase 2 Unknown 40 enrolled Brazilian National Cancer Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Brazil is a tropical country, with high incidence of ultraviolet radiation throughout the year. Many Europeans migrated to Brazil escaping either war or economic crisis to live in the country searching for opportunities. Low phototype combined with high incidence of UV light is a combination that not only affect the skin but also the lips. The current study was designed to use photodynamic therapy with metil 5-aminolevulinate for actinic cheilitis in a phase 2 clinical trial.

Timeline

Start
2019-10-17
Primary completion
2020-05-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule